Core Points - The document outlines the rules for the board of directors of Guangxi Liuyao Group Co., Ltd, aiming to standardize the decision-making process and enhance the board's operational efficiency [2][3][4] Summary by Sections Chapter 1: General Provisions - The rules are established to regulate the board's meeting procedures and decision-making processes, ensuring compliance with relevant laws and the company's articles of association [2] Chapter 2: Composition and Powers of the Board - The board consists of 7 directors, including 3 independent directors and 1 employee representative [3] - The board has various powers, including convening shareholder meetings, executing resolutions, deciding on business plans, and managing internal structures [4][5] Chapter 3: Convening and Notification of Board Meetings - The board must hold at least two meetings annually, with the chairman responsible for convening them [6] - The board can hold temporary meetings under specific circumstances, such as shareholder requests or regulatory requirements [6][7] Chapter 4: Conducting Board Meetings - A quorum requires more than half of the directors to be present, with specific rules for related party transactions [8][9] - Directors are expected to attend in person or delegate their voting rights appropriately [10][11] Chapter 5: Review Procedures and Resolutions - Proposals must be discussed thoroughly before voting, with a majority required for approval [12][13] - Directors must avoid conflicts of interest during voting, especially in related party transactions [14][15] Chapter 6: Miscellaneous - The rules will be interpreted and revised by the board, and any amendments must be approved by the shareholders [18]

Core Points - The document outlines the independent director system of Guangxi Liuyao Group Co., Ltd, aiming to enhance corporate governance and protect the rights of all shareholders, especially minority shareholders [1][2] - Independent directors are defined as those who do not hold any other positions within the company and must maintain independence from major shareholders and actual controllers [1][3] - The proportion of independent directors on the board must not be less than one-third, including at least one accounting professional [2][4] Summary by Sections General Principles - The independent director system is established to improve the governance structure of the company and ensure compliance with relevant laws and regulations [1] - Independent directors have a duty of loyalty and diligence to the company and all shareholders, participating in decision-making and providing professional advice [2] Qualifications of Independent Directors - Independent directors must meet specific qualifications, including legal and regulatory requirements, independence criteria, and relevant work experience [6][7] - Individuals with significant relationships with the company or its major shareholders are prohibited from serving as independent directors [3][4] Nomination, Election, and Replacement of Independent Directors - Independent director candidates can be proposed by the board or shareholders holding more than 1% of the company's shares, and must be elected by the shareholders' meeting [6][11] - The term for independent directors aligns with that of other directors, with a maximum continuous service of six years [8][9] Responsibilities and Duties of Independent Directors - Independent directors are responsible for participating in board decisions, supervising potential conflicts of interest, and providing objective advice to enhance decision-making [18][19] - They have special rights, including hiring external consultants and proposing meetings, to ensure their independence and effectiveness [19][20] Support for Independent Directors - The company must provide necessary working conditions and support for independent directors to fulfill their duties effectively [32][33] - Independent directors are entitled to the same rights to information as other directors, ensuring they can perform their roles without obstruction [34][35] Miscellaneous Provisions - The document includes definitions of key terms such as major shareholders and minority shareholders, and outlines the responsibilities of the board in interpreting and amending the system [39][41]

广西柳药集团股份有限公司 募集资金管理制度 (2025年8月修订) 第一章 总 则 同一投资项目所需资金原则上应当在同一募集资金专户存储。公司存在两次 以上融资的，应当分别设置募集资金专户。实际募集资金净额超过计划募集资金 金额（以下简称"超募资金"）也应当存放于募集资金专户管理。 第二条 本制度所称募集资金，是指公司通过发行股票或者其他具有股权性 质的证券，向投资者募集并用于特定用途的资金，但不包括公司实施股权激励计 划募集的资金。 第六条 公司应当在募集资金到账后 1 个月内与保荐人或者独立财务顾问、 商业银行签订募集资金专户存储三方监管协议。该协议至少应当包括以下内容： 第一条 为进一步规范广西柳药集团股份有限公司（以下简称"公司"）对募 集资金的使用和管理，提高募集资金的使用效率和效益，维护投资者的合法权益， 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司募集资金 监管规则》《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监 管指引第 1 号——规范运作》等相关法律、法规及规范性文件和《广西柳药集团 股份有限公司章程》（以下简称"《公司章程》"）的有关规定，结合公司实际 情况 ...

Group 1 - The core point of the article is the revised articles of association of Guangxi Liuyao Group Co., Ltd. which aim to protect the rights and interests of the company, shareholders, employees, and creditors while regulating the company's organization and behavior [1][2][3] - The company was established as a joint-stock company in accordance with the Company Law and other relevant regulations, with a registered capital of RMB 397,168,905 [2][3] - The company is committed to the health industry, providing professional pharmaceutical distribution services, and aims to become an innovative enterprise in the pharmaceutical circulation field [5][6] Group 2 - The company’s business scope includes wholesale and retail of pharmaceuticals, medical device operations, and various related services [5][6] - The company has issued a total of 397,168,905 shares, all of which are ordinary shares with a par value of RMB 1 per share [7][8] - The company can increase its capital through various methods, including issuing shares to unspecified objects or existing shareholders [10][11] Group 3 - The company’s shareholders have rights to dividends, participate in shareholder meetings, and supervise the company's operations [15][16] - The company must hold an annual general meeting within six months after the end of the previous fiscal year [50][51] - The company’s articles stipulate that any significant transactions must be approved by the board and submitted to the shareholders' meeting for approval [24][26]

Core Points - The document outlines the rules for the shareholders' meeting of Guangxi Liuyao Group Co., Ltd, ensuring compliance with relevant laws and regulations [2][22] - It specifies the procedures for convening, proposing, notifying, and conducting shareholders' meetings, emphasizing the rights of shareholders to participate and vote [4][10] Group 1: General Provisions - The rules are established to regulate the behavior of the company and ensure shareholders can exercise their rights according to the law [2] - The company must strictly follow legal and regulatory requirements when convening shareholders' meetings [3] Group 2: Convening Shareholders' Meetings - The board of directors is responsible for convening the annual and temporary shareholders' meetings within specified timeframes [4][5] - Independent directors and the audit committee have the right to propose temporary meetings, and the board must respond within ten days [8][9] Group 3: Proposals and Notifications - Shareholders holding more than 1% of shares can propose agenda items for the meeting, with specific timelines for submission [14][15] - Notifications for meetings must be sent out in advance, detailing all proposals and necessary information for shareholders to make informed decisions [16][17] Group 4: Conducting Shareholders' Meetings - Meetings must be held at the company's registered location or another specified venue, allowing for both in-person and remote participation [21][22] - The meeting must be presided over by the chairman or a designated representative, ensuring order and adherence to the agenda [30][31] Group 5: Voting Procedures - Resolutions can be classified as ordinary or special, with different voting thresholds required for approval [34][36] - Shareholders must vote on each proposal individually, and the results must be publicly announced [46][48] Group 6: Meeting Records - Detailed records of the meeting must be maintained, including attendance, proposals discussed, and voting outcomes [52] - The records should be preserved for a minimum of ten years to ensure transparency and accountability [52]

广西柳药集团股份有限公司 第一章 总则 第一条 为规范广西柳药集团股份有限公司（以下简称"柳药集团"或"公 司"）2025 年员工持股计划（以下简称"员工持股计划"或"本计划"）的实施， 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证 券法》（以下简称"《证券法》"）、《关于上市公司实施员工持股计划试点的指导 意见》（以下简称"《指导意见》"）、《上海证券交易所上市公司自律监管指引第 （以下简称"《规范运作》"）等相关法律、行政法规、规章、 规范性文件和《公司章程》、《广西柳药集团股份有限公司 2025 年员工持股计划 （草案）》之规定，特制定《广西柳药集团股份有限公司 2025 年员工持股计划管 理办法》（以下简称"本办法"）。 第二章 员工持股计划的制定 第二条 员工持股计划的目的 公司依据《公司法》《证券法》《指导意见》《规范运作》等有关法律、行政 法规、规章、规范性文件和《公司章程》的规定，制定了本计划。公司员工自愿、 合法、合规地参与员工持股计划，持有公司股票的目的在于建立和完善员工、股 东的利益共享机制，改善公司治理水平，提高职工的凝聚力和公司竞争力，调动 员工的积极性 ...

广西柳药集团股份有限公司 董事会薪酬与考核委员会工作细则 （2025 年 8 月修订） 第一章 总则 第一条 为进一步建立健全广西柳药集团股份有限公司（以下简称"公司"） 董事、高级管理人员的薪酬与考核管理制度，完善公司治理结构，有效实施公司 人才发展战略，根据《中华人民共和国公司法》 经董事长提议并经董事会讨论通过，可对委员会委员在任期内进行调整。 《上市公司治理准则》 《上海证券 交易所上市公司自律监管指引第 1 号——规范运作》等法律、法规和规范性文件 及《广西柳药集团股份有限公司章程》（以下简称"《公司章程》"）等有关规定， 公司设立董事会薪酬与考核委员会（以下简称"薪酬与考核委员会"），并结合公 司实际情况，制订本细则。 第二条 薪酬与考核委员会是董事会下设的专门委员会，主要负责制定公司 董事、高级管理人员的考核标准并进行考核；制定、审查公司董事、高级管理人 员的薪酬决定机制、决策流程、支付与止付追索安排等薪酬政策与方案，并提出 建议。 第三条 本细则所称董事是指在公司领取薪酬的非独立董事；高级管理人员 是指董事会聘任的总裁、副总裁、董事会秘书、财务总监及由总裁提请董事会认 定的其他高级管理人员。 ...

Core Points - The article outlines the establishment and operational guidelines of the Strategic Committee of Guangxi Liuyuan Pharmaceutical Group Co., Ltd. to enhance the company's core competitiveness and improve decision-making processes [1][2] - The Strategic Committee is responsible for researching and proposing suggestions on the company's long-term development strategies and major investment decisions [1][2] Group 1: General Provisions - The Strategic Committee is established to meet the strategic development needs of the company and to enhance its core competitiveness [1] - The committee is a specialized body under the board of directors, focusing on long-term strategies and significant investment decisions [1][2] Group 2: Composition of the Committee - The Strategic Committee consists of three directors, including at least one independent director [2] - The committee members are nominated by the chairman, a majority of independent directors, or at least one-third of all directors, and elected by the board [2] Group 3: Responsibilities and Authority - The main responsibilities of the Strategic Committee include researching long-term development strategies, evaluating major investment decisions, and checking the implementation of these matters [3][4] - The committee is accountable to the board of directors and must report its work and proposals for board review [3] Group 4: Decision-Making Procedures - The Investment Review Group, led by the company's president, prepares the necessary materials for the Strategic Committee's decisions [4][5] - The committee must hold meetings to discuss proposals from the Investment Review Group and submit the results to the board [4][5] Group 5: Meeting Rules - The Strategic Committee must hold at least one regular meeting annually, with provisions for additional meetings as needed [5][6] - Meetings require the presence of at least two-thirds of the committee members to be valid, and decisions must be approved by a majority [6][7] Group 6: Confidentiality and Record-Keeping - All participants in the committee meetings are bound by confidentiality regarding the discussed matters [7][8] - Meeting records must be maintained for at least ten years, and the committee's proposals must be submitted in writing to the board [7][8]

广西柳药集团股份有限公司 董事会提名委员会工作细则 （2025 年 8 月修订） 第一章 总则 第一条 为完善广西柳药集团股份有限公司（以下简称"公司"）的法人治 理结构，规范董事会成员和高级管理人员的产生，优化董事会组成，根据《中华 人民共和国公司法》《上市公司治理准则》《上海证券交易所上市公司自律监管 指引第 1 号——规范运作》等法律、法规和规范性文件及《广西柳药集团股份有 限公司章程》（以下简称"《公司章程》"）等有关规定，公司设立董事会提名 委员会（以下简称"提名委员会"），并结合公司实际情况，制订本细则。 第二条 提名委员会是董事会下设的专门委员会，主要负责拟定董事、高级 管理人员的选择标准和程序，对董事、高级管理人员人选及其任职资格进行遴选、 审核并提出建议。 第二章 人员组成 第三条 提名委员会由三名董事组成，其中独立董事应当过半数。 第四条 提名委员会委员由董事长、1/2 以上独立董事或者全体董事的 1/3 以 上提名，并由董事会选举产生。 第五条 提名委员会设主任委员（召集人）一名，由独立董事担任，负责主 持委员会工作。提名委员会主任委员由董事长提名，并经全体董事过半数选举产 生。 第七条 ...

Core Viewpoint - The document outlines the establishment and operational guidelines of the Audit Committee of Guangxi Liuyuan Pharmaceutical Group Co., Ltd, emphasizing its role in enhancing corporate governance and ensuring effective oversight of financial reporting and internal controls [1][2]. Group 1: General Provisions - The Audit Committee is established to improve the company's governance structure and ensure effective supervision of management [1]. - The committee is responsible for reviewing financial information, supervising internal and external audits, and evaluating internal controls [2]. Group 2: Composition of the Committee - The committee consists of at least three directors, with a majority being independent directors, and is chaired by an independent director with accounting expertise [3][4]. - The term of committee members aligns with their term as directors, and they can be re-elected [3][4]. Group 3: Responsibilities and Authority - The main responsibilities include reviewing financial reports, supervising management actions, proposing meetings, and evaluating external audit work [5][6]. - The committee must approve significant financial disclosures and the hiring or dismissal of external auditors [6][7]. Group 4: Internal Audit Oversight - The committee guides and supervises the internal audit department, reviews audit plans, and evaluates the effectiveness of internal controls [8][9]. - It is required to conduct checks on high-risk activities and report any violations to the relevant authorities [9]. Group 5: Meeting Procedures - The committee must hold at least one meeting per quarter, with provisions for special meetings as needed [12][13]. - A quorum of two-thirds of members is required for meetings, and decisions are made by majority vote [13][14]. Group 6: Information Disclosure - The company must disclose the composition and activities of the Audit Committee in its annual reports, including any significant issues identified during its oversight [16][17]. - Any recommendations made by the committee that are not adopted by the board must be disclosed with explanations [17].